william cooper Archives
Cooper named to key VUSM, Medical Center roles
Jan. 16, 2014—William O. Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics, professor and vice chair for Faculty Affairs in the Department of Pediatrics, and professor of Health Policy, has been promoted and will have two new roles. He will now also serve as associate dean for Faculty Affairs within the Faculty Affairs & Career Development Office in the Vanderbilt University School of Medicine and as director of the Vanderbilt Center for Patient and Professional Advocacy (CPPA).
Vanderbilt study shows suicide risk doesn’t differ in children taking two types of commonly prescribed antidepressants
Jan. 7, 2014—A new Vanderbilt University Medical Center study shows there is no evidence that the risk of suicide differs with two commonly prescribed antidepressants prescribed to children and adolescents.
Immunosuppressive drugs unlikely to raise fetal risk: study
Nov. 14, 2013—Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
Endowed chair celebration honors nine Vanderbilt faculty
Jan. 21, 2013—The extraordinary academic achievements of nine Vanderbilt University endowed chair holders were recognized during a Jan. 17 ceremony at the Student Life Center.
MPH Global Health track addresses emerging needs
Jan. 10, 2013—Vanderbilt University is working to train a health care workforce that will be more integrated and team-oriented than ever before. One of the educational programs addressing new needs is the Vanderbilt Master of Public Health (MPH) Program, which launched a new track in Global Health last year.
Vanderbilt study finds no heart risk in ADHD medications
Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
